The substance abuse treatment market is anticipated to grow at a CAGR of around 10.5% during the forecast period. Substance abuse is referred to as a set of conditions that are associated with the consumption of various mind- and behavior-altering substances. These substances impart a negative impact on the behavioral and health outcomes of the patient. Substance abuse significantly contributes to various economic, social, physical, mental, and public health problems hence, the need for the adoption of treatment is high.
Increasing acceptance and consumption of alcohol, nicotine, and drugs among the young population in emerging economies and the need to control the addiction is a key factor for the growth of the global substance abuse treatment market. Moreover, increasing disposable income is also driving the market. First, due to increased disposable income, people are more exposed to alcohol and drugs. Moreover, due to the same reason, significant capital expenditure is witnessed in the therapy session and medications.
The substance abuse treatment market has potential growth opportunities in the low- and middle-income economies owing to the presence of a huge addicted population. According to the World Health Organization (WHO), more than 80% of the 1.3 billion tobacco users across the globe are from low- and middle-income economies. However, the low awareness regarding the condition of substance abuse disorder and its negative impact among the population is hampering the growth of the market during the forecast period.
Segmental Outlook
The global substance abuse treatment market is segmented based on the treatment type and distribution channel. based on the treatment type, the market is sub-segmented into drug abuse treatment, nicotine addiction treatment, and alcohol addiction treatment. By distribution channel, the market is divided into retail and rehabilitation center.
The alcohol addiction treatment segment will contribute significantly to the growth
The alcohol addiction treatment segment is anticipated to grow with a significant CAGR in the near future. It is due to factors such as economic development, cultural acceptance, easy availability of alcohol, and many more. Moreover, alcohol dependence is also increasing due to the subtle implementation and enforcement of alcohol policies across the globe. According to the Centers for Disease Control (CDC) estimate, six people die every day from alcohol poisoning in the US. Therefore, a significant demand for alcohol addiction treatment will be witnessed during the forecast period.
Global Substance Abuse Treatment Market Share by Treatment Type, 2019 (%)
Regional Outlooks
The global substance abuse treatment market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to hold a major market share during the forecast period. The large market share in the region is owing to the developed healthcare infrastructure to cure addiction among people. Moreover, the increased awareness regarding substance abuse and its adverse social and health issues is expected to drive the substance abuse treatment market share in the region.
Global Substance abuse Treatment Market Growth, by Region 2020-2026
Asia-Pacific will augment with the fastest growth rate in the substance abuse treatment market
Asia-Pacific is anticipated to show the fastest growth rate in the substance abuse treatment market owing to the increasing cases of various substance abuse in emerging countries such as India, China, and Bangladesh. Additionally, the increasing illicit drug trafficking across the region is also expected to increase the population of substance abuse patients. Moreover, the surge in the rehab centers and various other settlements along with increasing disposable income will also fuel the market growth across Asia-Pacific.
Market Players Outlook
The key players of the substance abuse treatment market include Amphastar Pharmaceuticals, Inc., Adial Pharmaceuticals, BioCorRx, Inc., Purdue Pharma L.P., Pfizer Inc., Bristol Myers Squibb Co., Sun Pharmaceutical Industries Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including merger & acquisition, collaborations with government, and new product launches to stay competitive in the market. For instance, in June 2020, Purdue Pharma L.P. announced that it will Fund Harm Reduction Therapeutics, Inc.’s with $6.5 million of additional financial support for the development of a low-cost, over-the-counter (OTC) naloxone nasal spray in the US. The naloxone is an opioid antagonist rescue medication that is intended to reverse the effects of an opioid overdose.
The Report Covers
1. Report Summary
1.1. Research Business Functions and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Amphastar Pharmaceuticals, Inc.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Alkermes PLC
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Pfizer Inc.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Purdue Pharma L.P.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Alkermes plc
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.1. Opportunities
5. Market Segmentation
5.1. Global Substance Abuse Treatment Market by Treatment Type
5.1.1. Drug Abuse Treatment
5.1.1.1. Methadone
5.1.1.2. Buprenorphine
5.1.1.3. Naltrexone
5.1.1.4. Other
5.1.2. Nicotine Addiction Treatment
5.1.2.1. NRT Therapy
5.1.2.2. Varenicline
5.1.2.3. Bupropion
5.1.2.4. Other
5.1.3. Alcohol Addiction Treatment
5.1.3.1. Acamprosate
5.1.3.2. Disulfiram
5.1.3.3. Naltrexone
5.1.3.4. Benzodiazepines
5.1.3.5. Other
5.2. Global Substance Abuse Treatment Market by Distribution Channel
5.2.1. Retail
5.2.2. Rehabilitation Center
6. Regional Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Adial Pharmaceuticals Inc.
7.2. Alkermes PLC
7.3. Allergan plc (Subsidiary of AbbVie)
7.4. Amphastar Pharmaceuticals, Inc.
7.5. BioCorRx, Inc.
7.6. Bristol Myers Squibb Co.
7.7. Indivior PLC
7.8. Mallinckrodt PLC
7.9. Novartis AG (Sandoz)
7.10. Opiant Pharmaceuticals Inc.
7.11. Pfizer Inc.
7.12. Purdue Pharma L.P.
7.13. Reckitt Benckiser Group plc
7.14. Sun Pharmaceutical Industries Ltd.
1. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2019-2026 ($ MILLION)
2. GLOBAL DRUG ABUSE TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
3. GLOBAL NICOTINE ADDICTION TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
4. GLOBAL ALCOHOL ADDICTION TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
5. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
6. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2019-2026 ($ MILLION)
7. GLOBAL RETAIL SUBSTANCE ABUSE TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
8. GLOBAL REHABILITATION CENTER SUBSTANCE ABUSE TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
9. NORTH AMERICA SUBSTANCE ABUSE TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
10. NORTH AMERICAN SUBSTANCE ABUSE TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2019-2026 ($ MILLION)
11. NORTH AMERICAN SUBSTANCE ABUSE TREATMENT MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2019-2026 ($ MILLION)
12. EUROPE SUBSTANCE ABUSE TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
13. EUROPE SUBSTANCE ABUSE TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2019-2026 ($ MILLION)
14. EUROPE SUBSTANCE ABUSE TREATMENT MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2019-2026 ($ MILLION)
15. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
16. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2019-2026 ($ MILLION)
17. ASIA PACIFIC SUBSTANCE ABUSE TREATMENT MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2019-2026 ($ MILLION)
18. REST OF THE WORLD SUBSTANCE ABUSE TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2019-2026 ($ MILLION)
19. REST OF THE WORLD SUBSTANCE ABUSE TREATMENT MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2019-2026 ($ MILLION)
1. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SHARE BY TREATMENT TYPE, 2019 VS 2026 (%)
2. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SHARE BY DISTRIBUTION CHANNEL, 2019 VS 2026 (%)
3. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
4. US SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
5. CANADA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
6. UK SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
7. FRANCE SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
8. GERMANY SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
9. ITALY SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
10. SPAIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
11. ROE SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
12. INDIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
13. CHINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
14. JAPAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
15. REST OF ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)